PubRank

Georgia B Vogelsang

Author PubWeight™ 59.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant 2006 4.09
2 Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. Biol Blood Marrow Transplant 2006 2.63
3 Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant 2006 2.44
4 Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria. Blood 2011 2.26
5 National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report. Biol Blood Marrow Transplant 2006 2.24
6 Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood 2004 2.20
7 Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report. Biol Blood Marrow Transplant 2006 1.86
8 Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant 2010 1.69
9 A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change. Biol Blood Marrow Transplant 2011 1.54
10 Validation of measurement scales in ocular graft-versus-host disease. Ophthalmology 2011 1.50
11 Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial. Biol Blood Marrow Transplant 2010 1.34
12 Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD. Biol Blood Marrow Transplant 2010 1.33
13 Chronic graft versus host disease. Br J Haematol 2004 1.33
14 Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. Blood 2003 1.29
15 Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease. J Clin Oncol 2007 1.27
16 Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment. Biol Blood Marrow Transplant 2002 1.27
17 Stem cell transplantation: supportive care and long-term complications. Hematology Am Soc Hematol Educ Program 2002 1.24
18 Pentostatin in steroid-refractory acute graft-versus-host disease. J Clin Oncol 2005 1.15
19 Acute graft versus host disease. Orphanet J Rare Dis 2007 1.12
20 Clinical benefit of response in chronic graft-versus-host disease. Biol Blood Marrow Transplant 2012 1.10
21 Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion. Blood 2002 1.10
22 Infliximab for steroid-refractory acute GVHD: a case series. Am J Hematol 2003 1.06
23 Assessment of joint and fascia manifestations in chronic graft-versus-host disease. Arthritis Rheumatol 2014 1.04
24 Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions. Biol Blood Marrow Transplant 2006 0.99
25 Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study. Biol Blood Marrow Transplant 2003 0.97
26 Myxedema ascites in the posttransplant setting: case report. Am J Hematol 2002 0.94
27 Novel strategies for steroid-refractory acute graft-versus-host disease. Curr Opin Hematol 2005 0.93
28 Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical Trials. Biol Blood Marrow Transplant 2008 0.89
29 Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cells. Biol Blood Marrow Transplant 2003 0.89
30 Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma. Biol Blood Marrow Transplant 2007 0.88
31 A systematic approach to hepatic complications in hematopoietic stem cell transplantation. J Hematother Stem Cell Res 2002 0.87
32 Acute graft-versus-host disease. Clin Adv Hematol Oncol 2004 0.86
33 Gastrointestinal toxicity from the preparative regimen is associated with an increased risk of graft-versus-host disease. Biol Blood Marrow Transplant 2005 0.85
34 Anti-cytokine therapy for the treatment of graft-versus-host disease. Curr Pharm Des 2004 0.84
35 The effects of interleukin 10 and interferon gamma cytokine gene polymorphisms on survival after autologous bone marrow transplantation for patients with breast cancer. Biol Blood Marrow Transplant 2005 0.83
36 Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study. Blood 2009 0.83
37 Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L. Transfusion 2007 0.83
38 Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 x 10(9) or 20 x 10(9) per L. Transfusion 2007 0.82
39 Wasted sheep and premature infants: the role of trace metals in hematopoiesis. Blood Rev 2004 0.80
40 Lymphocytic pneumonitis as the manifestation of acute graft-versus-host disease of the lung. Am J Hematol 2005 0.80
41 Pentostatin - pharmacology, immunology, and clinical effects in graft-versus-host disease. Expert Opin Pharmacother 2004 0.79
42 Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging for acute myeloid leukaemia beyond first remission: a 10-year experience. Br J Haematol 2002 0.79
43 Grover's Disease after Bone Marrow Transplantation. Biol Blood Marrow Transplant 2007 0.79
44 Novel pharmacotherapeutic approaches to prevention and treatment of GVHD. Drugs 2002 0.79
45 Hepatic venoocclusive disease in blood and bone marrow transplantation in children: incidence, risk factors, and outcome. J Pediatr Hematol Oncol 2002 0.78
46 Chronic graft-versus-host disease. Curr Pharm Des 2008 0.78
47 Pentostatin for the treatment of chronic graft-versus-host disease in children. J Pediatr Hematol Oncol 2003 0.78
48 Mesenchymal stem cells and organ transplantation: current status and promising future. Transplantation 2006 0.77
49 Montelukast in chronic graft-versus-host disease: a breath of fresh air? Transplantation 2007 0.75
50 Rapid engraftment at a cost? Transplantation 2010 0.75
51 Keeping up with Blood: introducing our CME program. Blood 2010 0.75